Tokyo, Japan

Takumi Aoki

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kanagawa, JP (2004)
  • Tokyo, JP (2016 - 2021)

Company Filing History:


Years Active: 2004-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Takumi Aoki: Innovator in Therapeutic Agents

Introduction

Takumi Aoki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of autoimmune diseases and alopecia areata. With a total of 4 patents to his name, Aoki's work is recognized for its innovative approach to medical treatments.

Latest Patents

Aoki's latest patents include a therapeutic agent or preventive agent for alopecia areata. This agent exhibits RORγ antagonistic activity and includes a cyclic amine derivative as an active ingredient. Another notable patent focuses on a cyclic amine derivative that has retinoid-related orphan receptor γ antagonist activity. This compound shows therapeutic and preventive effects on autoimmune diseases such as multiple sclerosis and psoriasis, as well as allergic diseases like contact dermatitis and atopic dermatitis.

Career Highlights

Throughout his career, Takumi Aoki has worked with notable companies, including Toray Industries, Inc. and TDK Corporation. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Aoki has collaborated with several professionals in his field, including Shinnosuke Hayashi and Martial Vallet. These collaborations have further enhanced his research and development efforts.

Conclusion

Takumi Aoki is a distinguished inventor whose work in therapeutic agents has the potential to impact the treatment of various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…